Overview

An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.

Status:
Unknown status
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
This is a multicenter, randomized, open Label,add-on study.
Phase:
Phase 4
Details
Lead Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Treatments:
Anti-Asthmatic Agents
Antipyretics
Expectorants